Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance

Go back to Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance

Maravai LifeSciences (MRVI) Tops Q2 EPS by 13c

August 10, 2021 4:10 PM EDT

Maravai LifeSciences (NASDAQ: MRVI) reported Q2 EPS of $0.44, $0.13 better than the analyst estimate of $0.31. Revenue for the quarter came in at $217.8 million versus the consensus estimate of $192.29 million.

"Maravai had an incredibly strong first half of 2021, and we feel very good about... More